# OnCo record nct03906331 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03906331/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03906331", "NCT03906331" ;
  schema:name "Selpercatinib RET expanded access"@en ;
  schema:alternateName "Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation"@en ;
  schema:description "This expanded-access record concerns selpercatinib for cancers with activating RET changes. The registry now marks the program approved for marketing; this does not mean the former access program is recruiting."@en ;
  schema:url <https://onco.cc/trials/nct03906331/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03906331>, <https://clinicaltrials.ucsf.edu/trial/NCT03906331> ;
  onco:tag "ucsf-breast-coverage", "expanded-access" ;
  onco:phase "not-applicable" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/selpercatinib/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> .